Takeda Pharmaceuticals U.S.A., Inc.'s Net Worth

$0

Estimate Recalculated Nov 11, 2024 01:52PM EST

Who is Takeda Pharmaceuticals U.S.A., Inc.

Takeda Pharmaceuticals U.S.A., Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Molecular Templates, Inc., Cortexyme, Inc., Myovant Sciences Ltd., Ovid Therapeutics Inc., and Day One Biopharmaceuticals, Inc..

SEC CIK

Takeda Pharmaceuticals U.S.A., Inc.'s CIK is 0001716229

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Molecular Templates, Inc.

Investor
Updated Sep 08, 2017
Form 3
Sep 08, 2017
2.92M
Showing 1 results

Myovant Sciences Ltd.

Investor
Updated Mar 29, 2018
Form 3
Mar 29, 2018
7.42M
Showing 1 results

Day One Biopharmaceuticals, Inc.

Investor
Updated Dec 09, 2021
Form 4
-4.63%
-297.27K
$18.49
-$5.50M
Dec 09, 2021
6.12M
Sale
Dec 07 - Dec 08
Form 4
-1.69%
-110.21K
$18.10
-$1.99M
Dec 07, 2021
6.42M
Sale
Dec 03 - Dec 06
Form 4
0.88%
57.22K
Nov 29, 2021
6.53M
Acquisition
Nov 24
Showing 3 results

Cortexyme, Inc.

Investor
Updated May 13, 2019
Form 4
May 13, 2019
2.68M
Options
May 13
Form 3
May 08, 2019
Showing 2 results

Ovid Therapeutics Inc.

Investor
Updated Jul 06, 2022
Form 4
Jul 06, 2022
7.53M
Acq/Dis
Jul 01
Showing 1 results